BPG is committed to discovery and dissemination of knowledge
Articles in Press
2/5/2026 7:37:28 AM | Browse: 1 | Download: 0
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 117694
Country China
Category Radiology, Nuclear Medicine & Medical Imaging
Manuscript Type Retrospective Study
Article Title Tumor-related imaging parameters predict response and survival after neoadjuvant chemoradiotherapy in rectal cancer
Manuscript Source Unsolicited Manuscript
All Author List Ting-ting Nie, Yu-Xia Li, Xuan Yang, Tao Liu, Xiao-Hui Niu, Xiao-Fang Guo and Yu-Lin Liu
Funding Agency and Grant Number
Funding Agency Grant Number
Guiding Program of Natural Science Foundation of Hubei Province No. 2024AFC050
Special Project of Biomedical Research Center of Hubei Cancer Hospital No. 2022SWZX06
Hubei Province “Chutian Talents Program” Medical and Health Personnel Project No. CTYC001
Corresponding Author Xiao-Fang Guo, MD, PhD, Department of Radiology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 116 Zhuodaoquan South Road, Hongshan District, Wuhan 430079, Hubei Province, China. guoxiaofang2001@163.com
Key Words Sarcopenia; Rectal cancer; Neoadjuvant therapy; Response; Overall survival
Core Tip This study evaluated the impact of pretreatment sarcopenia and tumor-related magnetic resonance imaging parameters on the response to neoadjuvant chemoradiotherapy and overall survival in rectal cancer patients. The results show that while sarcopenia was not an independent predictor of treatment response or survival, tumor-related factors such as tumor length, mesorectal fascia involvement, and clinical T/N stage were significant predictors. These findings highlight the value of tumor-related imaging parameters in pretreatment risk stratification and personalized management for rectal cancer patients undergoing neoadjuvant chemoradiotherapy.
Citation Nie TT, Li YX, Yang X, Liu T, Niu XH, Guo XF, Liu YL. Tumor-related imaging parameters predict response and survival after neoadjuvant chemoradiotherapy in rectal cancer. World J Gastrointest Oncol 2026; In press
Received
2025-12-15 03:59
Peer-Review Started
2025-12-15 03:59
First Decision by Editorial Office Director
2025-12-24 09:40
Return for Revision
2025-12-24 09:40
Revised
2026-01-06 01:57
Publication Fee Transferred
2026-01-08 12:11
Second Decision by Editor
2026-02-05 02:47
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-02-05 07:37
Articles in Press
2026-02-05 07:37
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 1948-5204 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com